shortagewatch

Home / Nervous system / Ropivacaine

ATC N01BB09 · Anesthetics

Ropivacaine shortage

As of 31 Oct 2026, Ropivacaine has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 16 products.

Countries5/5
Products16packs or presentations
Short since22 Oct 20215.0 years ago
Earliest return1 Nov 2026company estimate
No return date1products
Main reasonManufacturing problem
Germany4 packs shortItaly3 packs shortSpain1 pack shortAustria1 pack shortBelgium7 packs short

Timeline

GermanyItalySpainAustriaBelgium
20222023202420252026Ropivacainhydrochlorid Kabi 2 mg/ml InjektioRopivacainhydrochlorid Kabi 2 mg/ml InjektionslösungRopivacainhydrochlorid Kabi 10 mg/ml InjektiRopivacainhydrochlorid Kabi 10 mg/ml InjektionslösungRopivacain HCl B. Braun 2 mg/ml Injektions-/Ropivacain HCl B. Braun 2 mg/ml Injektions-/InfusionslösungRopivacainhydrochlorid Kabi 7,5 mg/ml InjektRopivacainhydrochlorid Kabi 7,5 mg/ml InjektionslösungROPIVACAINA KABIROPIVACAINA KABIROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.ROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG , 5 bolsas de 100 mlRopivacain-HCl B. Braun 2 mg/ml Injektions-/Ropivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung, 20 StückRopivacaine Readyfusor 2 mg/ml inf. sol. (adRopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlRopivacaine Readyfusor 2 mg/ml inf. sol. (adRopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlRopivacaine Readyfusor 2 mg/ml inf. sol. (adRopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlNaropin 2 mg/ml inj. sol. epidur. amp. 5 x 2Naropin 2 mg/ml inj. sol. epidur. amp. 5 x 20 mlRopivacaine Fresenius Kabi 7.5 mg/ml inj. soRopivacaine Fresenius Kabi 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 mlRopivacaine Fresenius Kabi 5 mg/ml inj. sol.Ropivacaine Fresenius Kabi 5 mg/ml inj. sol. i.thec. amp. 5 x 10 mlNaropin 5 mg/ml inj. sol. i.thec. amp. 5 x 1Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DERopivacainhydrochlorid Kabi 2 mg/ml InjektionslösungFresenius Kabi Deutschland GmbH3 Aug 202616 Nov 2026Manufacturing problem
Probleme in der Herstellung
DERopivacainhydrochlorid Kabi 10 mg/ml InjektionslösungFresenius Kabi Deutschland GmbH17 Aug 20269 Nov 2026Manufacturing problem
Probleme in der Herstellung
DERopivacain HCl B. Braun 2 mg/ml Injektions-/InfusionslösungB. Braun Melsungen Aktiengesellschaft31 Aug 202627 Nov 2026Increased demand
Erhöhte Nachfrage
DERopivacainhydrochlorid Kabi 7,5 mg/ml InjektionslösungFresenius Kabi Deutschland GmbH30 Sep 202616 Nov 2026Manufacturing problem
Probleme in der Herstellung
ITROPIVACAINA KABIFRESENIUS KABI ITALIA S.R.L.4 Dec 2025not givenIncreased demand
Elevata richiesta
ITROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI S.P.A.10 Dec 202530 Nov 2026Manufacturing problem
Problemi produttivi: distribuzione contingentata
ITROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M.BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI S.P.A.21 Jan 202631 Dec 2026Manufacturing problem
Problemi produttivi: distribuzione contingentata
ESROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG , 5 bolsas de 100 mlFresenius Kabi España, S.A.U.25 Jun 202629 Nov 2026Not stated
ATRopivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung, 20 StückB. Braun Melsungen AG16 Sep 202620 Nov 2026Manufacturing problem
Verzögerung bei der Herstellung
BERopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlBioQ Pharma22 Oct 20211 Nov 2026Other
Other reason
BERopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlBioQ Pharma22 Oct 20211 Nov 2026Manufacturing problem
Delay in production
BERopivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 mlBioQ Pharma22 Oct 20211 Nov 2026Manufacturing problem
Delay in production
BENaropin 2 mg/ml inj. sol. epidur. amp. 5 x 20 mlSandoz20 Apr 20265 Feb 2027Increased demand
BERopivacaine Fresenius Kabi 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 mlFresenius Kabi19 Aug 202629 Nov 2026Manufacturing problem
Delay in production
BERopivacaine Fresenius Kabi 5 mg/ml inj. sol. i.thec. amp. 5 x 10 mlFresenius Kabi8 Oct 20267 Feb 2027Manufacturing problem
Delay in production
BENaropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 mlSandoz29 Oct 202628 May 2027Increased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Bupivacaine Levobupivacaine Lidocaine Lidocaine, Combinations Mepivacaine Prilocaine